12 results about "Hyperhidrosis" patented technology

Use of a composition comprising bacteria for odor reduction in the treatment of symptoms of tissue necrosis, wound secretions or putrid wounds or a disease selected from the group consisting of ozena, hyperhidrosis, osmidrosis, chronic urinary tract infections, chlamydial infections and halitosis; wherein the composition comprises the bacteria Lactobacillus acidophilus TYCA15, Lactobacillus salivarius, Bifidobacterium animalis, Bifidobacterium bifidum and Bifidobacterium longum in the ratio 1:1:1:1:1; and the composition totals 10 9 bacteria per gram of the composition.

The present disclosure relates to the treatment of a skin condition in a subject, including but not limited to one or more of luminosity, brightness, skin pore size, skin pore count, sebum production, sebum composition, overall skin quality, eyelid laxity, fine lines under the eye, fine lines on the face, laxity on the face, perioral rhytids, moderate to severe facial folds and wrinkles such as nasolabial folds, moderate to severe facial wrinkles such as smile lines or marionette lines, age-related midface contour deficiencies, dorsal hand to correct volume deficit, glabellar lines, correction of facila depressions, either due to injury or age-related, perioral wrinkles, lip commissures, crow's feet, facial rhytides, and forehead wrinkles, comprising applying to the skin of the subject a first composition derived from one or more sponges, and a second composition comprising one or more botulinum toxins. Also provided are compositions for use in the treatment of a skin condition in a subject, including but not limited to hyperhidrosis, comprising a first composition and a second composition, wherein (a) the first composition comprises Spongilla; and (b) the second composition comprises one or more botulinum toxins. Also provided are kits, including kits for the treatment of a skin condition in a subject including but not limited to hyperhidrosis, comprising a first composition and a second composition, wherein the first composition comprises Spongilla, and the second composition comprises one or more botulinum toxins.

The present invention relates to novel pyrrolidinium compounds, stereoisomers, hydrates or solvates thereof, which exhibit excellent binding capacity and antagonistic activity to muscarinic receptors, in particular muscarinic M3 receptors. The compounds of the present invention are useful in the treatment of muscarinic acetylcholine receptor mediated diseases, such as hyperhidrosis, excessive salivation, chronic obstructive pulmonary disease, chronic bronchitis, asthma, rhinitis, urinary incontinence, overactive bladder, gastroesophageal reflux disease, irritable bowel syndrome, and the like.

Compounds shown in Formula (I), pharmaceutical compositions, and methods of using related to muscarinic acetylcholine receptors. The compounds herein are typically muscarinic acetylcholine receptor antagonists, such as M3 antagonists, which can be used for treating a variety of disorders, conditions or diseases such as hyperhidrosis.

The application discloses a postoperative CH prediction method and system for hyperhidrosis based on multiple factors, and the method comprises the following steps: acquiring multiple groups of postoperative historical data of patients, including target variables and multiple characteristic variables which have influence on postoperative CH of hyperhidrosis, and pre-processing the historical data; representing the historical data of each patient in the form of a multi-dimensional feature vector, and dividing a training set and a verification set; constructing a Gaussian regression model, and selecting a radial basis kernel and white noise kernel as a covariance function; optimizing hyperparameters of the covariance function on the training set by maximizing a log-likelihood function; and inputting a current patient feature vector into the optimized model, and outputting a prediction result. The method can take into account small sample adaptability, multiple factor interaction analysis and ordered classification prediction, and provides a scientific basis for clinical decision-making.

The present invention relates to novel pyrrolidinium compounds, stereoisomers thereof, hydrates thereof, or solvates thereof, which exhibit excellent binding ability and antagonistic activity to muscarinic receptors, particularly muscarinic M3 receptors. [Solution] The compounds of the present invention are useful in treating muscarinic acetylcholine receptor-mediated diseases such as hyperhidrosis, excessive salivation, chronic obstructive pulmonary disease, chronic bronchitis, asthma, rhinitis, urinary incontinence, overactive bladder syndrome, gastroesophageal reflux disease, and irritable bowel syndrome.

A composition for use in the treatment of dermatoporosis, comprising: at least one boswellic acid, optionally in the form of a plant extract in a proportion of 0.1 to 15% by weight relative to the weight of the composition, a hyaluronan in a proportion of 0.1 to 15% by weight relative to the weight of the composition, said composition further having a proportion by weight of boswellic acid to hyaluronan of between 0.5 and 2 and an excipient phase in a proportion of 99.8% to 70% by weight relative to the weight of the composition, the excipient phase being aqueous-based.

The invention relates to the technical field of traditional Chinese medicines, in particular to a traditional Chinese medicine composition for treating palmoplantar pustulosis caused by deficiency of liver-yin and kidney-yin. The traditional Chinese medicine composition for treating palmoplantar pustulosis caused by liver-kidney yin deficiency is prepared from the following raw materials in parts by weight: 8 to 12 parts of rhizoma anemarrhenae, 7 to 13 parts of cortex phellodendri, 25 to 35 parts of fructus corni, 15 to 25 parts of herba taraxaci, 5 to 7 parts of liquorice root, 7 to 13 parts of fructus ligustri lucidi and 4 to 6 parts of radix polygoni multiflori preparata. The traditional Chinese medicine composition disclosed by the invention is taken together with soybean milk or soybean milk powder pulp, has a remarkable treatment effect on palmoplantar pustulosis caused by deficiency of liver-yin and kidney-yin, and also has a relatively good treatment effect on hidrosis of hands and feet, bromhidrosis and climacteric hectic fever caused by deficiency of liver-yin and kidney-yin.

The present invention provides cosmetic compositions and methods comprising a composition derived from a lotus plant effective to treat, reduce, ameliorate and / or eliminate signs and results of dermatological aging of the skin and / or to improve the aesthetic appearance of the skin. Further, the composition is provided for use in compositions and methods to treat, ameliorate and / or reduce hyperhidrosis (or sweating or perspiration), particularly facial perspiration. More particularly, the active composition is an extract of lotus and / or a blend of extracts of various species of the lotus family, such as NELUPURE (INCI: Propanediol (and) Glycerin (and) Nymphaea Caerulea Flower Extract (and) Nelumbo Nucifera Flower Extract). This active reduces sebum and perspiration and is used to provide cosmetic long-lasting compositions.

An apparatus for primary hyperhidrosis treatment, comprising: a treatment surface adapted to contact at least one patient body part; at least one thermal module, wherein the at least one thermal module is adapted to change a temperature at the treatment surface; and a thermal controller, wherein the thermal controller is configured to: receive a predetermined temperature adjustment treatment profile; and adjust over time, using the thermal module, the temperature of at least one portion of the treatment surface, based on the predetermined temperature adjustment treatment profile.

The present application relates to a kind of traditional Chinese medicine composition for treating hyperhidrosis and its application, it is related to traditional Chinese medicine technical field, by weight parts, the traditional Chinese medicine composition for treating hyperhidrosis is composed of the following raw materials: flat lying chrysanthemum sanqi 54~78 parts and Sedum lineare 15~28 parts.The present application uses flat lying chrysanthemum sanqi and Sedum lineare in appropriate proportion, and they are mutually synergistic, and a kind of traditional Chinese medicine composition for treating hyperhidrosis is prepared by mutual action, curative effect is remarkable, and compatibility is simple, provide a new means for the treatment of hyperhidrosis patient, with practical application value.

Salts of glycopyrrolate, including solid forms and formulations such as topicals thereof, are disclosed. Methods of making glycopyrrolate salts, including formulations such as topicals thereof, and methods of treating hyperhidrosis with salts of glycopyrrolate, and formulations such as topicals thereof, are disclosed.